Loading
Latest filing published 06 Oct 2026 for Arbutus Biopharma Corporation, €27.8M. Read the official filing
No signal scores available.
Roivant Sciences Ltd. has a single filing on record, published on 6 October 2026: a transaction of €27.8M in Arbutus Biopharma Corporation. One trade is not enough to describe a pattern. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration